Larry M Karnitz, PhD

  • 6609 Citations
  • 41 Scopus h-Index
1984 …2021

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Larry M Karnitz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


CDK12 in Ovarian Cancer

Karnitz, L. M.

National Institutes of Health


Project: Research project

  • Research Output

    • 6609 Citations
    • 41 Scopus h-Index
    • 72 Article
    • 4 Review article

    Effect of CHK1 Inhibition on CPX-351 Cytotoxicity in vitro and ex vivo

    Vincelette, N. D., Ding, H., Huehls, A. M., Flatten, K. S., Kelly, R. L., Kohorst, M. A., Webster, J., Hess, A. D., Pratz, K. W., Karnitz, L. M. & Kaufmann, S. H., Dec 1 2019, In : Scientific reports. 9, 1, 3617.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer

    Kanakkanthara, A., Huntoon, C. J., Hou, X., Zhang, M., Heinzen, E. P., O’Brien, D. R., Oberg, A. L., John Weroha, S., Kaufmann, S. H. & Karnitz, L. M., Dec 1 2019, In : Nature communications. 10, 1, 4632.

    Research output: Contribution to journalArticle

    Open Access
  • Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity

    Kurmi, K., Hitosugi, S., Wiese, E. K., Boakye-Agyeman, F., Gonsalves, W., Lou, Z., Karnitz, L. M., Goetz, M. P. & Hitosugi, T. D., Feb 6 2018, In : Cell Reports. 22, 6, p. 1365-1373 9 p.

    Research output: Contribution to journalArticle

  • 12 Scopus citations

    Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway

    Kurmi, K., Hitosugi, S., Yu, J., Boakye-Agyeman, F., Wiese, E. K., Larson, T. R., Dai, Q., Machida, Y., Lou, Z., Wang, L. M., Boughey, J. C., Kaufmann, S. H., Goetz, M. P., Karnitz, L. M. & Hitosugi, T. D., Dec 4 2018, In : Cell Metabolism. 28, 6, p. 833-847.e8

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

    Gojo, I., Beumer, J. H., Pratz, K. W., McDevitt, M. A., Baer, M. R., Blackford, A. L., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Levis, M. J., Dezern, A. E., Gladstone, D. E., Ji, J. J., Wang, L., Kinders, R. J., Pouquet, M., Ali-Walbi, I., Rudek, M. A., Poh, W. & 5 others, Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E., Feb 1 2017, In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

    Research output: Contribution to journalArticle

  • 23 Scopus citations